Issue |
BIO Web Conf.
Volume 59, 2023
2023 5th International Conference on Biotechnology and Biomedicine (ICBB 2023)
|
|
---|---|---|
Article Number | 03013 | |
Number of page(s) | 6 | |
Section | Clinical Trials and Medical Device Monitoring | |
DOI | https://doi.org/10.1051/bioconf/20235903013 | |
Published online | 08 May 2023 |
ELDTIP: An Ensemble Learning-based method for DTI Prediction
Institute of Problem Solving: Beijing University of Aeronautics and Astronautic, China
* E-mail: 23000230084@qq.com
Exploring drug-target interactions has always been an important step in drug development. However, exploring drug-target interaction is time-consuming and laborious. A large number of studies try to use artificial intelligence methods to predict possible drug-target interactions to reduce the workload of the wet-lab identification experiments. However, the accuracy of existing methods is still limited.
This paper proposes an ensemble learning-based drug-target interaction prediction method (ELDTIP in short). First, the multiple similarity matrices of drugs or proteins are integrated by singular value decomposition (SVD) to obtain their low-dimensional feature vectors. After that, by concatenating the low-dimensional feature vectors of specific drugs and targets, the feature vector of a drug-target pair are obtained. An ensemble learning model based on gradient boosting decision tree (GBDT) was constructed to predict whether this pair of drug-target can interact with each other. The main contributions of ELDTIP are as follows: (1): ELDTIP uses SVD to integrate multiple similarity matrices, which can retain more valuable information of the original feature. (2): ELDTIP uses the ensemble learning-based model, GBDT, which can make full use of the unknown DTIs in the dataset and mitigate the influence of class imbalance. Experimental results show that the performance of ELDTIP is higher than that of several state-of-the-art DTI prediction methods.
© The Authors, published by EDP Sciences, 2023
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.